Literature DB >> 20689566

Headache: migraine, magnetic stimulation and cortical excitability.

Yew L Lo.   

Abstract

A new study indicates that single-pulse transcranial magnetic stimulation can provide substantial long-lasting pain relief in patients with migraine with aura. The findings suggest that non-pharmacological therapies could be used to successfully abort migraine attacks in patients who find that drug therapies do not adequately control migraine symptoms.

Entities:  

Mesh：

Year:  2010        PMID： 20689566     DOI： 10.1038/nrneurol.2010.109

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  7 in total

Review 1.  Migraine aura pathophysiology: the role of blood vessels and microembolisation.

Authors:  Turgay Dalkara; Ala Nozari; Michael A Moskowitz
Journal:  Lancet Neurol       Date:  2010-03       Impact factor: 44.182

2.  Peri-ictal normalization of visual cortex excitability in migraine: an MEG study.

Authors:  W-T Chen; S-J Wang; J-L Fuh; C-P Lin; Y-C Ko; Y-Y Lin
Journal:  Cephalalgia       Date:  2009-04-09       Impact factor: 6.292

3.  Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine.

Authors:  V Bohotin; A Fumal; M Vandenheede; P Gérard; C Bohotin; A Maertens de Noordhout; J Schoenen
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

4.  Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.

Authors:  Richard B Lipton; David W Dodick; Stephen D Silberstein; Joel R Saper; Sheena K Aurora; Starr H Pearlman; Robert E Fischell; Patricia L Ruppel; Peter J Goadsby
Journal:  Lancet Neurol       Date:  2010-03-04       Impact factor: 44.182

5.  The threshold for phosphenes is lower in migraine.

Authors:  S K Aurora; K M A Welch; F Al-Sayed
Journal:  Cephalalgia       Date:  2003-05       Impact factor: 6.292

6.  Motor and occipital cortex excitability in migraine patients.

Authors:  Sefer Gunaydin; Aysun Soysal; Turan Atay; Baki Arpaci
Journal:  Can J Neurol Sci       Date:  2006-02       Impact factor: 2.104

7.  Peri-ictal changes of cortical excitability in children suffering from migraine without aura.

Authors:  Michael Siniatchkin; Anna-Lena Reich; Alex J Shepherd; Andreas van Baalen; Hartiwg R Siebner; Ulrich Stephani
Journal:  Pain       Date:  2009-09-30       Impact factor: 6.961
  7 in total
  6 in total

Review 1.  Safety of noninvasive brain stimulation in children and adolescents.

Authors:  Chandramouli Krishnan; Luciana Santos; Mark D Peterson; Margaret Ehinger
Journal:  Brain Stimul       Date:  2014-10-28       Impact factor: 8.955

2.  Chiropractic management of a patient with persistent headache.

Authors:  Jason West; Reed B Phillips
Journal:  J Chiropr Med       Date:  2013-12

3.  Auditory hallucinations and migraine of possible brainstem origin.

Authors:  Y L Lo; S Hameed; H Rumpel; L L Chan
Journal:  J Headache Pain       Date:  2011-06-04       Impact factor: 7.277

4.  Increased variability of motor cortical excitability to transcranial magnetic stimulation in migraine: a new clue to an old enigma.

Authors:  Adriana B Conforto; Mariana S Moraes; Edson Amaro; William B Young; Lais A Lois; André L Gonçalves; Mario F P Peres
Journal:  J Headache Pain       Date:  2011-09-01       Impact factor: 7.277

5.  Neuromagnetic abnormality of motor cortical activation and phases of headache attacks in childhood migraine.

Authors:  Jing Xiang; Xinyao Degrauw; Abraham M Korman; Janelle R Allen; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

6.  Quantitative neuromagnetic signatures of aberrant cortical excitability in pediatric chronic migraine.

Authors:  Kimberly A Leiken; Jing Xiang; Emily Curry; Hisako Fujiwara; Douglas F Rose; Janelle R Allen; Joanne E Kacperski; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  J Headache Pain       Date:  2016-04-26       Impact factor: 7.277
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.